Literature DB >> 31471642

[Tumor treatment of metastatic renal cell carcinoma : Comparison of immunotherapy with other drug options].

A Uhlig1,2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31471642     DOI： 10.1007/s00120-019-01038-2

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  15 in total

Review 1.  Immunotherapy of renal cell carcinoma. A critical appraisal from a urologist's point of view.

Authors:  G H Mickisch
Journal:  Urol Int       Date:  1999       Impact factor: 2.089

2.  Bias in meta-analysis detected by a simple, graphical test.

Authors:  M Egger; G Davey Smith; M Schneider; C Minder
Journal:  BMJ       Date:  1997-09-13

3.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

4.  Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology.

Authors:  Robert J Motzer; Jennifer Bacik; Tania Mariani; Paul Russo; Madhu Mazumdar; Victor Reuter
Journal:  J Clin Oncol       Date:  2002-05-01       Impact factor: 44.544

5.  Vaccination of metastatic renal cancer patients with MVA-5T4: a randomized, double-blind, placebo-controlled phase III study.

Authors:  Robert J Amato; Robert E Hawkins; Howard L Kaufman; John A Thompson; Piotr Tomczak; Cezary Szczylik; Mike McDonald; Sarah Eastty; William H Shingler; Jackie de Belin; Madusha Goonewardena; Stuart Naylor; Richard Harrop
Journal:  Clin Cancer Res       Date:  2010-09-29       Impact factor: 12.531

Review 6.  Renal cell carcinoma.

Authors:  R J Motzer; P Russo; D M Nanus; W J Berg
Journal:  Curr Probl Cancer       Date:  1997 Jul-Aug       Impact factor: 3.187

7.  Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States.

Authors:  Hiten D Patel; Mohit Gupta; Gregory A Joice; Arnav Srivastava; Ridwan Alam; Mohamad E Allaf; Phillip M Pierorazio
Journal:  Eur Urol Oncol       Date:  2018-09-25

Review 8.  Treatment options for metastatic renal cell carcinoma: a review.

Authors:  Uzma Athar; Teresa C Gentile
Journal:  Can J Urol       Date:  2008-04       Impact factor: 1.344

9.  Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.

Authors:  Daniel Y C Heng; Wanling Xie; Meredith M Regan; Mark A Warren; Ali Reza Golshayan; Chakshu Sahi; Bernhard J Eigl; J Dean Ruether; Tina Cheng; Scott North; Peter Venner; Jennifer J Knox; Kim N Chi; Christian Kollmannsberger; David F McDermott; William K Oh; Michael B Atkins; Ronald M Bukowski; Brian I Rini; Toni K Choueiri
Journal:  J Clin Oncol       Date:  2009-10-13       Impact factor: 44.544

Review 10.  Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review.

Authors:  Kiran Gupta; Jeffrey D Miller; Jim Z Li; Mason W Russell; Claudie Charbonneau
Journal:  Cancer Treat Rev       Date:  2008-03-04       Impact factor: 12.111
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.